Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01295229 · ClinicalTrials.gov registry record · NA
Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT01295229 is a NA study that has completed, run by University of Washington. The registered enrollment target is 43 participants.
The verdict
NCT01295229, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The escalating pandemics of obesity and type 2 diabetes mellitus (T2DM) are among the most significant contributors to morbidity and mortality worldwide. Roux-en-Y gastric bypass (RYGB) surgery causes profound weight loss and dramatically ameliorates T2DM through mechanisms beyond just weight loss, but its role in diabetes management and the nature of its weight-independent anti-diabetes effects are not well established because of a paucity of appropriate randomized trials, the execution of which is hindered by numerous obstacles. The investigators therefore propose a feasibility study to demonstrate our capacity to identify, recruit, randomize, and track outcomes for 40 adult Group Health members identified as having T2DM and a BMI between 30-40 kg/m2.
Interventions
- BEHAVIORAL Lifestyle Intervention
- PROCEDURE laparoscopic Roux-en-Y gastric bypass (RYGB) procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-05 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01295229
The ClinicalTrials.gov registry entry for NCT01295229 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lifestyle Intervention is the first listed.
NCT01295229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01295229 about?
NCT01295229 is a clinical study titled "Calorie Reduction Or Surgery: Seeking Remission for Obesity And Diabetes". The escalating pandemics of obesity and type 2 diabetes mellitus (T2DM) are among the most significant contributors to morbidity and mortality worldwide. Roux-en-Y gastric bypass (RYGB) surgery causes profound weight loss and dramatically ameliorates T2DM through mechanisms beyond just weight loss, ...
What is the current status of trial NCT01295229?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2011-05. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01295229?
The interventions under investigation include: Lifestyle Intervention (BEHAVIORAL), laparoscopic Roux-en-Y gastric bypass (RYGB) procedure (PROCEDURE).
Who is sponsoring clinical trial NCT01295229?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.